Michael A. Kirschenbaum
- Molecular Biology
- Nephrology top 2%
- Pharmacology top 5%
- Physiology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Vaijinath S. KamannaDaeyoung RohAnshumali ChaudhariJames H. SteinDeyou ZhengErika PedrosaRyan MokhtariHerbert M. Lachman
- Topics
- Inflammatory mediators and NSAID effects (10 papers)Electrolyte and hormonal disorders (8 papers)Eicosanoids and Hypertension Pharmacology (7 papers)
- Cited by
- NephrologyBiochemistryPharmacology
- Partner nations
- United StatesCzechiaSouth Korea
In The Last Decade
Michael A. Kirschenbaum
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 503
- Nephrology 295
- Pharmacology 215
- Physiology 209
- Pulmonary and Respiratory Medicine 194
Countries citing papers authored by Michael A. Kirschenbaum
This map shows the geographic impact of Michael A. Kirschenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Kirschenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Kirschenbaum more than expected).
Fields of papers citing papers by Michael A. Kirschenbaum
This network shows the impact of papers produced by Michael A. Kirschenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Kirschenbaum. The network helps show where Michael A. Kirschenbaum may publish in the future.
Co-authorship network of co-authors of Michael A. Kirschenbaum
This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Kirschenbaum. A scholar is included among the top collaborators of Michael A. Kirschenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Kirschenbaum. Michael A. Kirschenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 35 | |
| 5 | 43 | |
| 6 | 35 | |
| 7 | 6 | |
| 8 | 20 | |
| 9 | 41 | |
| 10 | 4 | |
| 11 | 31 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 31 | |
| 15 | 3 | |
| 16 | 27 | |
| 17 | 2 | |
| 18 | 14 | |
| 19 | 2 | |
| 20 | The effect of synthetic prostaglandin e 2 on blood pressure renal hemodynamics the kallikrein kinin renin angiotensin and prostaglandin systems | 9 |
About Michael A. Kirschenbaum
Michael A. Kirschenbaum is a scholar working on Nephrology, Biochemistry and Immunology and Allergy, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Electrolyte and hormonal disorders (8 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Nephrology (295 citations), Biochemistry (157 citations) and Pharmacology (215 citations). Michael A. Kirschenbaum has collaborated with scholars based in United States, Czechia and South Korea. Frequent co-authors include Vaijinath S. Kamanna, Daeyoung Roh, Anshumali Chaudhari, James H. Stein, Deyou Zheng, Erika Pedrosa, Ryan Mokhtari, Herbert M. Lachman, Ping Wang and Ambalal Chaudhari. Their work appears in journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.